Lawrence Hamel

Title: The Innovative Contributions of Lawrence Hamel

Introduction

Lawrence Hamel is a notable inventor based in Pacific Grove, CA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Hamel has made strides in developing innovative drug delivery systems that enhance patient care.

Latest Patents

Hamel's latest patents include an "Apparatus for administering small volume oral transmucosal dosage forms." This invention focuses on systems and methods for administering small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a specialized device. The dispensing device features a lock-out mechanism and a means to prevent saliva and moisture ingress, ensuring that the drug dosage forms remain dry prior to administration. Another significant patent is for "Small-volume oral transmucosal dosage forms," which includes NanoTabs® that contain a predetermined amount of a pharmaceutically active drug. These NanoTabs® are designed for applications such as treating acute, post-operative, or breakthrough pain.

Career Highlights

Hamel is currently associated with Acelrx Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug delivery methods, which can significantly impact patient outcomes.

Collaborations

Hamel has collaborated with notable colleagues, including Pamela Palmer and Andrew I Poutiatine, who share his commitment to advancing pharmaceutical technologies.

Conclusion

Lawrence Hamel's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to improving drug delivery systems. His work continues to pave the way for advancements in patient care and treatment options.